Examination of publicly available gene expression datasets demonstrated that pediatric MLLr ALL expresses high BCL-2 mRNA levels, consistent with previous findings in a smaller subset of pediatric ALL patients (Robinson et al., 2008). The gene discussed is BCL2; the disease is acute lymphoblastic leukemia.